COMMUNIQUÉS West-GlobeNewswire

MyoKardia to Present at Two Upcoming Investor Conferences in September
29/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]
Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results
29/08/2018
- Continued advancement of endocrinology rare disease pipeline, paving way for application of TransCon ™ technology in a new therapeutic area - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, [...]
OncoMed to Present at Two Upcoming Investor Conferences in September
29/08/2018
REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today [...]
Align Technology to Speak at an Upcoming Financial Conference
29/08/2018
SAN JOSE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, [...]
The Hydropothecary Corporation Changes Name to HEXO Corp. and Announces Voting Results from Special Meeting of Shareholders
29/08/2018
GATINEAU, Quebec, Aug. 29, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that it has changed its corporate name from “The Hydropothecary Corporation [...]
Hydropothecary se dote d’un nouveau nom – HEXO Corp. – et annonce les résultats du scrutin tenu à son assemblée extraordinaire des actionnaires
29/08/2018
GATINEAU, Québec, 29 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX: HEXO) a le plaisir d’annoncer qu’elle a changé sa dénomination sociale, et qu’à partir d’aujourd’hui, elle [...]
NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB
29/08/2018
WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB [...]
New study on intensive rapid response system treatment in end-of-life care
29/08/2018
Study appears in September 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Many intensive interventions are delivered after rapid [...]
Assure Holdings Sets Second Quarter 2018 Conference Call for Thursday, August 30, 2018, at 11:00 a.m. ET
29/08/2018
DENVER, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Thursday, [...]
OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
GAITHERSBURG, Md., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at the 20 th Annual Rodman & [...]
Trading in Coloplast shares by board members, executives or associated persons
29/08/2018
Nasdaq Copenhagen 29 August 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on [...]
RAMSAY GENERALE DE SANTE : annual Results at the end of June 2018
29/08/2018
PRESS RELEASE Paris, 29 August 2018 Annual results at the end of June 2018 Resilient operating results in an unfavourable context Annual published turnover rose 0.3% to EUR 2,241.5 million (a 0.7% increase on a like-for [...]
RAMSAY GENERALE DE SANTE : résultats annuels à fin juin 2018
29/08/2018
COMMUNIQUE DE PRESSE Paris, le 29 Août 2018 Résultats annuels à fin juin 2018 Des résultats opérationnels résilients dans un contexte défavorable Chiffre d'affaires annuel publié en hausse de 0,3% à 2241,5 millions d' [...]
The Alliance for Regenerative Medicine Releases Agenda for 2018 Cell & Gene Meeting on the Mesa
29/08/2018
WASHINGTON, DC, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative [...]
Departure of Managing Director & Chief Executive Officer
29/08/2018
SYDNEY, Australia and MINNEAPOLIS, Aug. 29, 2018 (GLOBE NEWSWIRE) -- The Board of Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF) , today announced that Mr. Jack Cosentino will cease as Managing Director [...]
Tempus Announces $110 Million in Series E Financing
29/08/2018
CHICAGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today it has secured an [...]
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum
29/08/2018
TORONTO, ON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has entered into a Letter of Intent to acquire an interest or participate in the development [...]
Addressing a Leading Cause of Pregnancy-Related Death Among U.S. Women
29/08/2018
Stop the Clot, Spread the Word™ Public Health Education Effort Emphasizes Preventing Blood Clots in Pregnant Women VIENNA, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Blood clots are a leading cause of pregnancy-related [...]
Patent reinforces AroCell’s opportunities in the US market
29/08/2018
AroCell AB has received a Notice of Allowance stating that the U.S. Patent and Trademark Office intends to grant the company's patent application no. 15/105,999 titled ”Monoclonal Anti-TK1 Antibodies”. The patent [...]

Pages